LIR Life Sciences Corp. (CSE:SKNY)
Canada · Delayed Price · Currency is CAD 0.1350
-0.0050 (-3.57%)
At close: Oct 29, 2026
LIR Life Sciences Company Description
LIR Life Sciences Corp. operates as biopharmaceutical company that develops transdermal delivery system through formulations of GLP-1 combination therapies for obesity and metabolic disorders. The company is based in Vancouver, Canada.
LIR Life Sciences Corp.
| Country | Canada |
| Founded | 2024 |
| Industry | Pharmaceutical Preparations |
| CEO | Edward Mills |
Contact Details
Address: 1505 West 2nd Avenue Vancouver, BC V6J 1H2 Canada | |
| Phone | (888) 436 7772 |
| Website | lirlifesciences.com |
Stock Details
| Ticker Symbol | SKNY |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | May - April |
| Reporting Currency | CAD |
| ISIN Number | CA50206C1005 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Edward Mills | Chief Executive Officer |
| Harpreet Nijjar | Chief Financial Officer |